On Invalid Date, Hepion Pharmaceuticals (NASDAQ: HEPA) reported Q4 2023 earnings per share (EPS) of -$2.42, up 7.63% year over year. Total Hepion Pharmaceuticals earnings for the quarter were -$11.06 million. In the same quarter last year, Hepion Pharmaceuticals's earnings per share (EPS) was -$2.62.
As of Q2 2024, Hepion Pharmaceuticals's earnings has grown year over year. Hepion Pharmaceuticals's earnings in the past year totalled -$48.93 million.
What is HEPA's earnings date?
Hepion Pharmaceuticals's earnings date is Invalid Date. Add HEPA to your watchlist to be reminded of HEPA's next earnings announcement.
What was HEPA's revenue last quarter?
On Invalid Date, Hepion Pharmaceuticals (NASDAQ: HEPA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Hepion Pharmaceuticals's revenue was $0.00.
What was HEPA's revenue growth in the past year?
As of Q2 2024, Hepion Pharmaceuticals's revenue has grown null year over year. Hepion Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.